- Integrated Diagnostics announced the launch of its new Egypt-based subsidiary 'Wayak' to invest in data mining and artificial intelligence platforms.

Wayak would leverage the company's patient database to capture 'new growth opportunities in the healthcare management space and offer targeted services to its customers,' the company said.

With a database covering more than 13m patients, of which about 10% suffered from chronic diseases, Wayak would allow Integrated Diagnostics to 'build electronic medical records of patients and better cater to their needs with new value propositions,' it added.

Wayak, a joint venture, was 94% owned by IDH and 6% owned by renowned data analytics scientist and angel investor Dr. Khaled Ismail.

At 10:07am: [LON:IDHC] Integrated Diagnostics Holdings Plc share price was -0.05p at 4.73p

Story provided by